Platelet biology, role in disease

Role of platelet-derived microparticles in tumor biology and tissue regeneration

Endothelial-derived miicroparticules: biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis

Prolonged functions of platelets regulate thrombosis and inflammation

Platelet-Granulocyte interactions

Immune response

Platelets toll-like receptor expression: the link between "danger" ligands and inflammation

Clinical approaches for studying Fc receptors: lessons from rituximab pharmacogenetics

Regulated glycosylation patterns of IgG during alloimmune responses against human platelet antigens

Regulatory T cell compartment in ITP patients on treatment with thrombopoietic agents

Application of platelet antibody test results in the diagnosis of immune platelet disorders and the utility of platelet antigen bead arrays

LIFECODESTM PAK LxTM A multiparameter assay for detection of antibodies to Human Platelet Antigens

Drug-induced thrombocytopenia    

Drug-induced immune thrombocytopenia: Pathogenesis and diagnosis

Fetal/maternal interface

Placental immunology and maternal alloimmune responses

Materno-fetal interface: lessons from physiology towards therapeutics

Neonatal alloimmune thrombocytopenia 1

T-cell Responses Associated with Neonatal Alloimmune Thrombocytopenia

Fetomaternal Alloimmune Thrombocytopenia (FMAIT) and immunomodulation

Pathogenesis of Fetal and Neonatal Immune Thrombocytopenia: Lessons from animal models

 Oral abstracts: Alloimmune thrombocytopenia

OA01 - T-cell responses associated with neonatal alloimmune thrombocytopenia: the role of the allogeneic Leu33 residue in HPA-1a

OA02 - HLA-DRB3*0101 exhibits a dose-dependent impact on maternal HPA 1a-antibody levels in HPA 1a-immunized women

OA03 -Effect of HPA-1a peptides on in vivo anti-HPA-1a responses

OA04 - Maternal antibodies to fetal platelet GPIbα cause more frequent miscarriage than anti-β3 integrin antibodies in animal models of fetal and neonatal immune thrombocytopenia (FNIT): A possible explanation for low reported incidence of anti-GPIbα mediated FNIT

OA05 - A high affinity monoclonal anti-HPA-1a antibody derived from memory B cells of a woman alloimmunized in connection with pregnancy

OA06 - Prophylactic administration of anti-β3 antibodies induced antibody mediated immune suppression (AMIS) and prevented severe clinical complications in a murine model of fetal and neonatal alloimmune thrombocytopenia (FNAIT)

OA07 - In vivo assesment of an asn-297-linked n-glycan modified HPA-1a-specific monoclonal antibody for the treatment of neonatal alloimmune thrombocytopenia

Genetic disorders and platelet polymorphisms

MYH9-related disorders: from gene to therapy

Platelet glycoprotein VI deficiencies

GT, lessons regarding structure-function relationships

αΙΙbβΙΙΙ polymorphisms and structure modelling

Platelet transfusions: future challenges

In vitro platelet formation

Autoimmune thrombocytopenia

An update on the immunopathogenesis of ITP

Novel Treatments of ITP

Alan Waters' Award

OA08 - Development of novel reagents to study the presentation of HPA-1a peptide in the context of HLA-DRA/DRB3*0101 by maternal antigen presenting cells

Immune thrombocytopenia: current investigations in platelet immunology

Experience with Immucor automated Capture technology for Platelet Immunohematology

Combination of Capture P and BioArray technology in the establishment of an HPA1 negative donor file

Experience with implementing platelet crossmatching and its effect on patient outcomes

Roundtable discussion

Immunoglobulins

Mechanisms of action of IVIg in ITP

Mechanisms of action of IVIg in autoimmune and inflammatory diseases: an update

 Oral abstracts: Autoimmunity, Platelet miscellaneous

OA09 - Endoglycosidase f treatment prevents autoantibody-mediated clearance of human platelet in an in vivo model of immune thrombocytopenia

OA10 - Efficacy of steroid therapy in ameliorating ITP mediated by anti-platelet GPIIbIIIa versus GPIbα antibodies

Coffee Break / Exhibition visit and poster session

 Heparin-induced thrombocytopenia

Heparin-induced thrombocytopenia: Is there a genetic predisposition?

Class I HLA antibodies are the major cause of indeterminate serotonin releae assay (SRA) test results in heparin-induced thrombocytopenia (HIT)

Oral abstracts: Platelet immunology laboratory testing

OA12 - Platelet genotyping of low frequency antigens: a one year experience

OA13 - Detection of low avidity HPA-1a antibodies in neonatal alloimmune thrombocytopenia (NAIT) using surface plasmon resonance

Granulocyte immunobiology

Developments in the detection of HNA and HLA antibodies

Human Neutrophil Alloantigens - an update

The role of HLA class II antibodies in TRALI

Role of human neutrophil antigen-2a in inflammation

Leukocyte antibodies in TRALI

Neonatal alloimmune thrombocytopenia 2

Animal Model in Platelet Immunology

Non-invasive fetal blood typing for platelet and red cell antigens

Round Table Discussion on Neonatal Alloimmune Thrombocytopenia, management, screening programme?